Background： Sepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and ...

Interleukin-1 (IL-1) is a key molecule involved in inflammation and plays an important role in both healthy and diseased states. In disease, high levels of IL-1 in the brain are linked to ...

EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding ...

白细胞介素（IL-4，Interleukin-4）是免疫系统中的一种重要调节因子，它参与感染、过敏、自身免疫和癌症等多种免疫反应。而重组IL-4（重组白介素4，AbMole，M10465）为免疫细胞的培养和分化诱导，以及细胞和动物实验提供了重要工具。

We reviewed dozens of studies and spoke with researchers to find out whether any supplements demonstrate anti-inflammatory ...

DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...

The findings could provide a new approach to repairing tissue damage caused by radiation or chemotherapy treatment. A new ...

DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 - - New preclin ...

Exertional Heat Stroke is life-threatening and requires immediate whole-body cold-water immersion to prevent multiple organ failure.

Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical data at EADV 2025 for GS-6791 (NX-0479), a ...